PVC: Expert Review and Considerations for the Future Panel Session Brief

8th GHTF Conference - Ottawa, Canada

This brief is also available in Word and PDF format.

Title of Panel Session:	PVC: Expert Review and Considerations for the Future
Time:	Wednesday, 20 September 2000 9:00 am - 11:30 am
Chair:	John S. Parks VP, Regulatory and Quality Baxter Corporation
Panel Participants:	Irwin Hinberg, PhD Health Canada Device Surveillance Division Medical Devices Bureau
	Jon Cammack, PhD PVC Taskforce Research Director, Baxter Healthcare Corporation AdvaMed (Advanced Medical Technology Association)
	Speaker, TBA United States Food and Drug Administration
	Speaker, TBA National Toxicology Program
	Speaker, TBA EUCOMED
Topic:	Panelists will discuss the following: The National Toxicology Program Research (NTP) and findings regarding the PVC DEHP issue; the Health Canada and US Food and Drug Administration review and findings regarding PVC; European concerns and approaches to dealing with the environmental, health and safety issues and concerns regarding PVC and DEHP; the industry study of the safety of poly vinyl chloride issues in response to issues raised over the years; industry response to health and safety concerns; and the future of PVC and non PVC materials in drug containers and medical devices. Regulators and manufacturers of medical devices and pharmaceutical packager utilizing poly vinyl chloride will benefit from the panel presentations and open discussion regarding recent assessments of safety of PVC and phthalates.

Updated 22 July 2004